Lymphopenia and mortality in adult sepsis: A systematic review and focused meta-analysis of prognostic evidence

Precision immunotherapy to improve sepsis outcomes: the ImmunoSep randomized clinical trial

10.1001/jama.2025.24175 · doi-reference

Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis

10.1038/s41419-019-2015-1 · doi-reference

Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis (1532–8171 (Electronic))

10.1016/j.ajem.2019.10.023 · doi-reference

Pooled prevalence of lymphopenia in all-cause hospitalisations and association with infection: a systematic review and meta-analysis

10.1186/s12879-023-08845-1 · doi-reference

A consensus immune dysregulation framework for sepsis and critical illnesses

10.1038/s41591-025-03956-5 · doi-reference

The impact of pathogens on sepsis prevalence and outcome

10.3390/pathogens13010089 · doi-reference

Apoptosis-induced lymphopenia in sepsis and other severe injuries

10.1007/s10495-016-1325-3 · doi-reference

Sepsis and septic shock

10.1038/nrdp.2016.45 · doi-reference

Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit

10.1186/cc9309 · doi-reference

Profound lymphopenia and bacteraemia

10.1111/j.1445-5994.2006.01076.x · doi-reference

Relation between lymphopenia and bacteraemia in UK adults with medical emergencies

10.1136/jcp.2004.017335 · doi-reference

Sepsis endotypes defined by lymphocyte thresholds and inflammation inform precision immunomodulation

10.1002/mco2.70561 · doi-reference

Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial

10.1186/s13613-023-01109-w · doi-reference

The role of PD-1/PD-L1 and IL-7 in lymphocyte dynamics and sepsis progression: a biomarker study in critically ill patients

10.3390/ijms252312612 · doi-reference

Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial

10.1172/jci.insight.98960 · doi-reference

Association between D-dimer to lymphocyte ratio and in hospital all-cause mortality in elderly patients with sepsis: a cohort of 1123 patients

10.3389/fcimb.2024.1507992 · doi-reference

Enhancing prognostic accuracy in sepsis: a modified SOFA score incorporating lymphocyte count as an immune function marker

10.3389/fcimb.2025.1593589 · doi-reference

Prognostic value of neutrophils-to-lymphocytes ratio and platelets-to-lymphocytes ratio in sepsis patients with lymphopenia

10.1177/11772719231223156 · doi-reference

Assessment of soluble PD-L1 in septic shock in relation to immunosuppressive phenotypes

10.1016/j.aicoj.2025.100007 · doi-reference

Monocyte-macrophage membrane expression of IL-1R2 is a severity biomarker in sepsis

10.1038/s41419-025-07597-x · doi-reference

Predictive value of soluble programmed cell death ligand-1 in the progression of septic patients to chronic critical illness in the intensive care unit: a prospective observational clinical study

10.1097/shk.0000000000002156 · doi-reference

Prognostic significance of immune abnormalities in children with severe sepsis

10.1007/s12098-025-05872-5 · doi-reference

Enhanced insights into immunity traits of elderly patients in the intensive care unit with infections: evidence from a multicenter, prospective observational study

10.1186/s13054-025-05616-z · doi-reference

Endogenous IL-7 variation in relation to lymphocyte subtypes in septic patients

10.3390/medicina61020258 · doi-reference

Assessment of sepsis-induced immunosuppression at ICU discharge and 6 months after ICU discharge

10.1186/s13613-017-0304-3 · doi-reference

Myeloid cells in sepsis-acquired immunodeficiency

10.1111/nyas.14333 · doi-reference

Sepsis leads to lasting changes in phenotype and function of memory CD8 T cells

10.7554/elife.70989 · doi-reference

Association of leukocyte subpopulations identified by flow cytometry with outcomes of sepsis in a respiratory intensive care unit: an observational study

10.1177/08850666231193962 · doi-reference

Activation-associated accelerated apoptosis of memory B cells in critically ill patients with sepsis

10.1097/ccm.0000000000002380 · doi-reference

Early alterations of B cells in patients with septic shock

10.1186/cc12750 · doi-reference

A machine learning-based prediction model for poor prognosis in sepsis using lymphocyte count: a national, multicenter prospective cohort

10.1038/s41598-025-33980-x · doi-reference

Impact of baseline lymphopenia on prognosis of patients with septic shock

10.1186/s12879-025-12078-9 · doi-reference

Characteristics and clinical prognosis of septic patients with persistent lymphopenia

10.1177/08850666241226877 · doi-reference

Measuring inconsistency in meta-analyses

10.1136/bmj.327.7414.557 · doi-reference

Sepsis-induced immunosuppression

10.1146/annurev-physiol-061121-040214 · doi-reference

Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

10.1038/nri3552 · doi-reference

The immunopathology of sepsis and potential therapeutic targets

10.1038/nri.2017.36 · doi-reference

Lymphopenia in sepsis: a narrative review

10.1186/s13054-024-05099-4 · doi-reference

Persistent lymphopenia after diagnosis of sepsis predicts mortality

10.1097/shk.0000000000000234 · doi-reference

Lymphopenia in sepsis-an acquired immunodeficiency?

10.1111/imcb.12611 · doi-reference